Retatrutide is an investigational peptide being studied for its activity across the GLP-1, GIP, and glucagon receptor pathways. Because it engages multiple metabolic signaling systems, it has become a compound of interest in research focused on energy balance, glucose regulation, lipid metabolism, endocrine signaling, and body composition–related pathways.
In laboratory settings, Retatrutide may be used to explore how coordinated receptor activity influences metabolic response, nutrient utilization, insulin-related signaling, appetite and satiety pathways, and overall energy expenditure. Its multi-receptor profile makes it especially relevant for studies examining the interaction between incretin signaling and glucagon-mediated metabolic processes.
